The Surgical Clinical Trials Office (SCTO) is comprised of dedicated healthcare professionals who work collaboratively with industry, government, academia and philanthropy to provide comprehensive and efficient research services. The mission of SCTO is
to promote innovative high quality human research for improving outcomes while ensuring the highest level of patient safety. This is accomplished by conducting a variety of clinical trials using novel drugs and devices, which increase the number of
treatment options available to Beaumont patients. Realizing the best research standards through adherence to government policies and regulations is paramount. SCTO supports surgical investigational teams through process improvement, innovative technologies,
and education and training initiatives, while collaborating with academic institutions in translational research initiatives.
SCTO participates in a broad range of research, from basic science studies to clinical drug and device trials for FDA submission. To accomplish this endeavor SCTO works in partnership with multiple surgical specialties such as cardiovascular surgery,
vascular surgery, general surgery, colorectal surgery, plastic surgery, neurosurgery, surgical intensive care, anesthesia, and surgical laboratories. Numerous surgical residents and fellows participate in these programs, adding further to their training
experiences.
Currently, clinical researchers coordinate over 30 trials that are in various stages of enrollment and follow-up. These clinical trials involve:
- new classes of drugs and drug combinations for improving outcomes in surgery for breast cancer, ophthalmology, vascular surgery, anesthesia, and colorectal surgery
- minimally invasive technologies are utilized in vascular surgery and cardiothoracic surgery
- novel devices used as tertiary treatment options for stroke